Premium
Nonrandom chromosome breakpoints at Xq26 and 2q33 characterize cemento‐ossifying fibromas of the orbit
Author(s) -
Sawyer Jeffrey R.,
Tryka A. Frandne,
Bell Jane M.,
Boop Frederick A.
Publication year - 1995
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19951115)76:10<1853::aid-cncr2820761026>3.0.co;2-d
Subject(s) - orbit (dynamics) , chromosome , medicine , breakpoint , fibroma , anatomy , biology , genetics , gene , engineering , aerospace engineering
Background . Cytogenetic reports of histologically benign fibroosseous lesions are rare, with only nine previously reported cases. None of these previous studies revealed consistent numerical or structural chromosome aberrations, and to the authors' knowledge, no karyotypic abnormalities in cemento‐ossifying fibromas of the orbit have been reported. Methods . Short term in situ culture and Giesma‐band chromosome methods were used to analyze three cementifying fibromas of the orbit: one from a 13‐year‐old African American male, one from a 14‐year‐old Hispanic male, and one from a 17‐year‐old white male. Results . Cytogenetic findings in these three cases revealed the presence of identical chromosomal breakpoints occurring in all three tumors at bands Xq26 and 2q33. Two of the tumors showed an identical t(X;2)(q26;q33) reciprocal translocation as the sole abnormality. The third tumor revealed an interstitial insertion of bands 2q24.2q33 into Xq26 as the sole abnormality. Conclusions . The authors described new nonrandom breakpoints in fibroosseous lesions of the orbit, which can result from at least two different types of structural chromosomal aberrations. The identification of recurring breakpoints at Xq26 and 2q33 provides a new Cytogenetic tumor marker for the identification of this tumor subtype. The sublocalization of breakpoints in this tumor should provide important information for the precise localization and characterization of genes involved in the histiogenesis of these lesions. Cancer 1995:1853–9.